×
For best experience we recommend to activate Javascript in your browser.
ARHGAP44 antibody (C-Term)
This anti-ARHGAP44 antibody is a Rabbit Polyclonal antibody detecting ARHGAP44 in WB, ELISA, IHC and FACS. Suitable for Human.
Quick Overview for ARHGAP44 antibody (C-Term) (ABIN2351715)
Target
See all ARHGAP44 Antibodies
ARHGAP44
(rho GTPase Activating Protein 44 (ARHGAP44))
Reactivity
All reactivities for ARHGAP44 antibodies
Human
Host
All hosts for ARHGAP44 antibodies
Rabbit
Clonality
All clonalities for ARHGAP44 antibodies
Polyclonal
Conjugate
All conjugates for ARHGAP44 antibodies
This ARHGAP44 antibody is un-conjugated
Application
All applications for ARHGAP44 antibodies
Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Flow Cytometry (FACS)
Product Details anti-ARHGAP44 Antibody
(hide)
Binding Specificity
All epitopes for ARHGAP44 antibodies
AA 791-819, C-Term
Cross-Reactivity
Human
Cross-Reactivity (Details)
Calculated cross reactivity: Hu
Characteristics
RICH2, CT (ARHGAP44, KIAA0672, RICH2, Rho GTPase-activating protein 44, NPC-A-10, Rho-type GTPase-activating protein RICH2, RhoGAP interacting with CIP4 homologs protein 2)
Purification
Purified by Protein A affinity chromatography.
Immunogen
RICH2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 791-819 amino acids from the C-terminal region of human RICH2.
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working conditions should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
-20°C
Target Details for ARHGAP44
(hide)
Target
ARHGAP44
(rho GTPase Activating Protein 44 (ARHGAP44))
Alternative Name
RICH2
NCBI Accession
NP_055674
UniProt
Q17R89
Recently viewed
(hide)
Chat with us , powered by LiveChat